Sort
130,381 grants matching “hiv”
ENHANCED COMPREHENSIVE HIV PREVENTION PLANNING AND IMPLEMENTATION FOR THE BALTIMO
$878,896Claudia E. Gray · Maryland State Department Of Health · U65 · FY2010 · PS
Alphavirus Replicon Vaccines against Botulinum Neurotoxin
$878,891Robert A. Olmsted · Alphavax Human Vaccines, Inc. · U01 · FY2007 · AI
COMPREHENSIVE HIV PREVENTION PROJECT FOR HEALTH DEPTS
$878,865Mary McIntyre · Alabama State Dept Of Public Health · U62 · FY2016 · PS
LOUISIANA COMMUNITY AIDS RESEARCH PROGRAM (CPCRA)
$878,859Tulane University Of Louisiana · U01 · FY2004 · AI
LOUISIANA COMMUNITY AIDS RESEARCH PROGRAM (CPCRA)
$878,859Tulane University Of Louisiana · U01 · FY2003 · AI
Biostatistics Core
$878,846Rebecca S. Gelman · Harvard University · P30 · FY2016 · AI
Preclinical Evaluation of Novel Adenovirus Prime-Boost HIV-1 Vaccine
$878,835Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2009 · AI
Project 1: PREVENT Program Critical Path Project
$878,739Daniel Tuse · University Of Louisville · U19 · FY2016 · AI
Systems biology of HIV, methamphetamine and antiretrovirals interactions
$878,554Pietro P Sanna · Scripps Research Institute, The · R01 · FY2018 · DA
POLYCOMB REPRESSIVE COMLEXE AS KEY REGULATORS OF HIV LATENCY AND TARGETS FOR LATENCY REVERSAL
$878,498Lindsey Ingerman James · Univ Of North Carolina Chapel Hill · R33 · FY2023 · DA
POLYCOMB REPRESSIVE COMLEXE AS KEY REGULATORS OF HIV LATENCY AND TARGETS FOR LATENCY REVERSAL
$878,498Lindsey Ingerman James · Univ Of North Carolina Chapel Hill · R33 · FY2022 · DA
Molecular Interactions Of Lymphoid Cell Receptors
$878,412David H. Margulies · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
HIV, Inflammation, and Endothelial Dysfunction
$878,381Samir Kumar Gupta · Indiana University Indianapolis · R01 · FY2010 · HL
Cardiovascular Disease Mechanisms in HIV Infected and Uninfected Veterans
$878,370Matthew S Freiberg · University Of Pittsburgh At Pittsburgh · R01 · FY2010 · HL
Structure, Dynamics and Activation Mechanisms of Chemokine Receptors
$878,282Tracy M Handel · University Of California, San Diego · U01 · FY2011 · GM
The Danger Model 2: how tissues control Immunity
$878,217Polly C Matzinger · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
Therapuetic effector functions of AAV-expressed transgenes
$878,155Ronald C Desrosiers · Scripps Florida · P01 · FY2015 · AI
NNTC Data Coordinating Center
$878,134Howard S. Fox · University Of Nebraska Medical Center · U24 · FY2020 · MH
Clinical and Population Sciences
$878,106Paul A Volberding · University Of California, San Francisco · P30 · FY2014 · AI
Clinical Core
$877,948Daniel W Fitzgerald · Weill Medical Coll Of Cornell Univ · U19 · FY2016 · AI
In vivo CRISPR engineering of B cells to produce anti-HIV broadly neutralizing antibodies using novel nanoparticles
$877,927Jennifer Eileen Adair · Fred Hutchinson Cancer Center · R01 · FY2022 · AI
Clinical Trial Site Monitoring for PHOENIx MDR-TB
$877,923Kimberly Smith · Ppd Development Lp · N01 · FY2021 · AI
Increasing available choices for conjugate vaccine technology by producing carrier proteins in Scarab Genomicsâ reduced genome E. coli strains
$877,755Frederick R Blattner · Scarab Genomics, Llc · R44 · FY2017 · AI
Immune based interventions for HIV eradication
$877,752Mirko Paiardini · Emory University · R01 · FY2016 · AI
Molecular And Immunopathology Of Experimental And Clinical Ocular Diseases
$877,682Chi-Chao Chan · National Eye Institute · ZIA · FY2014 · EY